Biorion Technologies BV

BiOrion Technologies BV is a biopharmaceutical company, dedicated to the development of "next generation" drugs for the treatment of severe, chronic and life-threatening diseases. 

BiOrion develops advanced "personalized medicine" drugs for simultaneous diagnosis and treatment of diseases such as liver- and pancreatic cancer, liver cirrhosis and kidney fibrosis through specific targeting to PDGF- and IGF-II-expressing diseased cells. 

We own technologies to modify the distribution of effective drugs thereby increasing drug concentration in the diseased cells and leaving the healthy cells unaffected. 

The products of BiOrion allow cell-specific therapies and diagnostics providing a novel approach in lethal diseases for which no effective therapy is currently available.